Published in Neuropharmacology on March 15, 2010
Antiepileptic drugs and pregnancy outcomes. Am J Med Genet A (2012) 0.92
Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential. Epilepsia (2013) 0.86
Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4. Bipolar Disord (2014) 0.79
Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus. Epilepsia (2014) 0.76
Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities. J Neurosci (2017) 0.75
Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase. Int J Mol Sci (2017) 0.75
A putative flip-flop switch for control of REM sleep. Nature (2006) 4.67
The mammalian gene function resource: the International Knockout Mouse Consortium. Mamm Genome (2012) 2.65
Neural tube defects and folate: case far from closed. Nat Rev Neurosci (2006) 2.30
A new partner for the international knockout mouse consortium. Cell (2007) 2.23
Large-scale gene trapping in C57BL/6N mouse embryonic stem cells. Genome Res (2008) 2.08
Nociception in kyoto. Pain (2008) 2.06
Maternal periconceptional vitamins: interactions with selected factors and congenital anomalies? Epidemiology (2002) 1.93
The planar cell polarity effector Fuz is essential for targeted membrane trafficking, ciliogenesis and mouse embryonic development. Nat Cell Biol (2009) 1.90
The continuing challenge of understanding, preventing, and treating neural tube defects. Science (2013) 1.86
Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A (2005) 1.82
118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet (2009) 1.74
Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology (2004) 1.63
A mouse model of hereditary folate malabsorption: deletion of the PCFT gene leads to systemic folate deficiency. Blood (2011) 1.62
Mid-pregnancy cotinine and risks of orofacial clefts and neural tube defects. J Pediatr (2008) 1.52
Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study. Clin Ther (2012) 1.47
Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol (2007) 1.44
Dynamic genotype-selective "phenotypic switching" of CGRP expression contributes to differential neuropathic pain phenotype. Exp Neurol (2013) 1.43
Parity violating energetic difference and enantiomorphous crystalsp-caveats; reinvestigation of tyrosine crystallization. Orig Life Evol Biosph (2006) 1.40
Association of selected persistent organic pollutants in the placenta with the risk of neural tube defects. Proc Natl Acad Sci U S A (2011) 1.38
Novel mutations in VANGL1 in neural tube defects. Hum Mutat (2009) 1.37
Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci U S A (2005) 1.33
Valproate decreases inositol biosynthesis. Biol Psychiatry (2004) 1.33
The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia (2004) 1.26
Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab (2003) 1.25
Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology (2002) 1.22
Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A (2005) 1.18
Choline and risk of neural tube defects in a folate-fortified population. Epidemiology (2009) 1.18
Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet (2002) 1.17
Burst discharge in primary sensory neurons: triggered by subthreshold oscillations, maintained by depolarizing afterpotentials. J Neurosci (2002) 1.17
Folic acid in early pregnancy: a public health success story. FASEB J (2010) 1.16
Maternal occupational exposure to polycyclic aromatic hydrocarbons: effects on gastroschisis among offspring in the National Birth Defects Prevention Study. Environ Health Perspect (2012) 1.16
Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit (2003) 1.15
3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Res (2006) 1.14
Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation. J Clin Invest (2010) 1.14
Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Epilepsy Res (2005) 1.13
Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol (2004) 1.13
Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res (2010) 1.10
Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn (2004) 1.10
Key role of the dorsal root ganglion in neuropathic tactile hypersensibility. Eur J Pain (2004) 1.09
Reduced folate carrier polymorphism (80A-->G) and neural tube defects. Eur J Hum Genet (2003) 1.08
Valproic Acid: second generation. Neurotherapeutics (2007) 1.08
Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J (2009) 1.07
Folate pathway and nonsyndromic cleft lip and palate. Birth Defects Res A Clin Mol Teratol (2010) 1.06
Spontaneous neural tube defects in splotch mice supplemented with selected micronutrients. Toxicol Appl Pharmacol (2005) 1.06
Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet (2002) 1.06
Oscillatory mechanism in primary sensory neurones. Brain (2002) 1.06
Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons. J Neurosci (2005) 1.06
Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia (2003) 1.05
Investigations into the etiology of neural tube defects. Birth Defects Res C Embryo Today (2004) 1.05
Electrical excitability of the soma of sensory neurons is required for spike invasion of the soma, but not for through-conduction. Biophys J (2003) 1.05
Whole genome microarray analysis, from neonatal blood cards. BMC Genet (2009) 1.05
Teratogenic effects of antiepileptic drugs. Expert Rev Neurother (2010) 1.05
Are the betaine-homocysteine methyltransferase (BHMT and BHMT2) genes risk factors for spina bifida and orofacial clefts? Am J Med Genet A (2005) 1.04
HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. Gastroenterology (2010) 1.04
Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol (2005) 1.04
Epidemiologic characteristics of anophthalmia and bilateral microphthalmia among 2.5 million births in California, 1989-1997. Am J Med Genet A (2005) 1.04
Autoantibodies to folate receptor during pregnancy and neural tube defect risk. J Reprod Immunol (2008) 1.03
Chronic pain as a disease in its own right. Pain Pract (2004) 1.03
Fuz controls the morphogenesis and differentiation of hair follicles through the formation of primary cilia. J Invest Dermatol (2010) 1.01
Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res (2005) 1.00
Neural and orofacial defects in Folp1 knockout mice [corrected]. Birth Defects Res A Clin Mol Teratol (2003) 1.00
Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia (2007) 0.99
Causes of pain in degenerative bone and joint disease: a lesson from vertebroplasty. Pain (2003) 0.99
Fuz mutant mice reveal shared mechanisms between ciliopathies and FGF-related syndromes. Dev Cell (2013) 0.99
Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol (2003) 0.99
Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China. Ann Epidemiol (2005) 0.99
Simulation in sensory neurons reveals a key role for delayed Na+ current in subthreshold oscillations and ectopic discharge: implications for neuropathic pain. J Neurophysiol (2009) 0.98
Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol (2003) 0.98
Maternal smoking, genetic variation of glutathione s-transferases, and risk for orofacial clefts. Epidemiology (2005) 0.98
Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice. Toxicol Lett (2003) 0.98
Mutations in planar cell polarity gene SCRIB are associated with spina bifida. PLoS One (2013) 0.98
Embryonic development in the reduced folate carrier knockout mouse is modulated by maternal folate supplementation. Birth Defects Res A Clin Mol Teratol (2008) 0.98
Keratinocytes acting on injured afferents induce extreme neuronal hyperexcitability and chronic pain. Pain (2009) 0.97
Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model. Birth Defects Res B Dev Reprod Toxicol (2008) 0.97
The paradox of pain from tooth pulp: low-threshold "algoneurons"? Pain (2011) 0.97
Subthreshold oscillations induced by spinal nerve injury in dissociated muscle and cutaneous afferents of mouse DRG. J Neurophysiol (2002) 0.97
Defective sumoylation pathway directs congenital heart disease. Birth Defects Res A Clin Mol Teratol (2011) 0.97
Renal tubular reabsorption of folate mediated by folate binding protein 1. J Am Soc Nephrol (2005) 0.96
The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium. Dis Model Mech (2011) 0.95
Maternal and infant gene-folate interactions and the risk of neural tube defects. Am J Med Genet A (2012) 0.95
Time course of substance P expression in dorsal root ganglia following complete spinal nerve transection. J Comp Neurol (2006) 0.94
Differentially expressed genes in embryonic cardiac tissues of mice lacking Folr1 gene activity. BMC Dev Biol (2007) 0.94
Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology (2013) 0.94
Combining the enantioselectivities of L-valine diamide and permethylated beta-cyclodextrin in one gas chromatographic chiral stationary phase. Anal Chem (2006) 0.94
Spontaneous pain following spinal nerve injury in mice. Exp Neurol (2007) 0.93
DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutr (2002) 0.93
Importance of folate-homocysteine homeostasis during early embryonic development. Clin Chem Lab Med (2007) 0.93
Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice. Birth Defects Res A Clin Mol Teratol (2005) 0.93
Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A (2007) 0.93
Correlational analysis for identifying genes whose regulation contributes to chronic neuropathic pain. Mol Pain (2009) 0.93
Maternal occupational chemical exposures and biotransformation genotypes as risk factors for selected congenital anomalies. Am J Epidemiol (2003) 0.93
Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives. Biochem Pharmacol (2005) 0.92
Antiepileptic drugs and pregnancy outcomes. Am J Med Genet A (2012) 0.92